Your browser doesn't support javascript.
loading
Neurodegenerative VPS41 variants inhibit HOPS function and mTORC1-dependent TFEB/TFE3 regulation.
van der Welle, Reini E N; Jobling, Rebekah; Burns, Christian; Sanza, Paolo; van der Beek, Jan A; Fasano, Alfonso; Chen, Lan; Zwartkruis, Fried J; Zwakenberg, Susan; Griffin, Edward F; Ten Brink, Corlinda; Veenendaal, Tineke; Liv, Nalan; van Ravenswaaij-Arts, Conny M A; Lemmink, Henny H; Pfundt, Rolph; Blaser, Susan; Sepulveda, Carolina; Lozano, Andres M; Yoon, Grace; Santiago-Sim, Teresa; Asensio, Cedric S; Caldwell, Guy A; Caldwell, Kim A; Chitayat, David; Klumperman, Judith.
Afiliação
  • van der Welle REN; Section Cell Biology, Center for Molecular Medicine, Institute of Biomembranes, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Jobling R; Department of Pediatrics, Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
  • Burns C; Department of Biological Sciences, Division of Natural Sciences and Mathematics, University of Denver, Denver, CO, USA.
  • Sanza P; Section Cell Biology, Center for Molecular Medicine, Institute of Biomembranes, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • van der Beek JA; Section Cell Biology, Center for Molecular Medicine, Institute of Biomembranes, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Fasano A; Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, ON, Canada.
  • Chen L; Division of Neurology, University of Toronto, Toronto, ON, Canada.
  • Zwartkruis FJ; Krembil Brain Institute, Toronto, ON, Canada.
  • Zwakenberg S; Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, ON, Canada.
  • Griffin EF; Department of Biological Sciences, Division of Natural Sciences and Mathematics, University of Denver, Denver, CO, USA.
  • Ten Brink C; Section Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Veenendaal T; Section Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Liv N; Department of Biological Sciences, The University of Alabama, Tuscaloosa, AL, USA.
  • van Ravenswaaij-Arts CMA; Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, Nathan Shock Center for Basic Research in the Biology of Aging, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.
  • Lemmink HH; Section Cell Biology, Center for Molecular Medicine, Institute of Biomembranes, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Pfundt R; Section Cell Biology, Center for Molecular Medicine, Institute of Biomembranes, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Blaser S; Section Cell Biology, Center for Molecular Medicine, Institute of Biomembranes, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Sepulveda C; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Lozano AM; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Yoon G; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Santiago-Sim T; Department of Diagnostic Imaging, Hospital for Sick Children, Toronto, ON, Canada.
  • Asensio CS; Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, ON, Canada.
  • Caldwell GA; Division of Neurology, University of Toronto, Toronto, ON, Canada.
  • Caldwell KA; Krembil Brain Institute, Toronto, ON, Canada.
  • Chitayat D; Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, ON, Canada.
  • Klumperman J; Department of Neurosurgery, Toronto Western Hospital, UHN, Toronto, ON, Canada.
EMBO Mol Med ; 13(5): e13258, 2021 05 07.
Article em En | MEDLINE | ID: mdl-33851776
ABSTRACT
Vacuolar protein sorting 41 (VPS41) is as part of the Homotypic fusion and Protein Sorting (HOPS) complex required for lysosomal fusion events and, independent of HOPS, for regulated secretion. Here, we report three patients with compound heterozygous mutations in VPS41 (VPS41S285P and VPS41R662* ; VPS41c.1423-2A>G and VPS41R662* ) displaying neurodegeneration with ataxia and dystonia. Cellular consequences were investigated in patient fibroblasts and VPS41-depleted HeLa cells. All mutants prevented formation of a functional HOPS complex, causing delayed lysosomal delivery of endocytic and autophagic cargo. By contrast, VPS41S285P enabled regulated secretion. Strikingly, loss of VPS41 function caused a cytosolic redistribution of mTORC1, continuous nuclear localization of Transcription Factor E3 (TFE3), enhanced levels of LC3II, and a reduced autophagic response to nutrient starvation. Phosphorylation of mTORC1 substrates S6K1 and 4EBP1 was not affected. In a C. elegans model of Parkinson's disease, co-expression of VPS41S285P /VPS41R662* abolished the neuroprotective function of VPS41 against α-synuclein aggregates. We conclude that the VPS41 variants specifically abrogate HOPS function, which interferes with the TFEB/TFE3 axis of mTORC1 signaling, and cause a neurodegenerative disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article